| David C Brandon, MD | |
|
8464 Aveley Farm Road, Easton, MD 21601 | |
| (301) 317-0020 | |
| (301) 317-0028 |
| Full Name | David C Brandon |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 38 Years |
| Location | 8464 Aveley Farm Road, Easton, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922137942 | NPI | - | NPPES |
| 066861300 | Medicaid | MD | |
| 050087601 | Other | RAILROAD MEDICARE | |
| 65501 | Other | MD | IND BS MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D40120 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Easton Anesthesia Associates, Llc | 5890076830 | 7 |
News Archive
For the first time, engineers have demonstrated an electronic device to closely monitor beating heart cells without affecting their behavior. A collaboration between the University of Tokyo, Tokyo Women's Medical University and RIKEN in Japan produced a functional sample of heart cells with a soft nanomesh sensor in direct contact with the tissue.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
CHI-California Healthcare Institute announced today that registration is now open for CHI's 2011 Annual Meeting. CHI's Annual Meeting focuses on the relationship between biomedical innovation and public policy. This year's theme is Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model.
› Verified 6 days ago
| Entity Name | North American Partners In Anesthesia Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093707879 PECOS PAC ID: 1850283144 Enrollment ID: O20040330000405 |
News Archive
For the first time, engineers have demonstrated an electronic device to closely monitor beating heart cells without affecting their behavior. A collaboration between the University of Tokyo, Tokyo Women's Medical University and RIKEN in Japan produced a functional sample of heart cells with a soft nanomesh sensor in direct contact with the tissue.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
CHI-California Healthcare Institute announced today that registration is now open for CHI's 2011 Annual Meeting. CHI's Annual Meeting focuses on the relationship between biomedical innovation and public policy. This year's theme is Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model.
› Verified 6 days ago
| Entity Name | First Colonies Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740218767 PECOS PAC ID: 8426039744 Enrollment ID: O20040525000119 |
News Archive
For the first time, engineers have demonstrated an electronic device to closely monitor beating heart cells without affecting their behavior. A collaboration between the University of Tokyo, Tokyo Women's Medical University and RIKEN in Japan produced a functional sample of heart cells with a soft nanomesh sensor in direct contact with the tissue.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
CHI-California Healthcare Institute announced today that registration is now open for CHI's 2011 Annual Meeting. CHI's Annual Meeting focuses on the relationship between biomedical innovation and public policy. This year's theme is Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model.
› Verified 6 days ago
| Entity Name | Easton Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316491236 PECOS PAC ID: 5890076830 Enrollment ID: O20170105000279 |
News Archive
For the first time, engineers have demonstrated an electronic device to closely monitor beating heart cells without affecting their behavior. A collaboration between the University of Tokyo, Tokyo Women's Medical University and RIKEN in Japan produced a functional sample of heart cells with a soft nanomesh sensor in direct contact with the tissue.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
CHI-California Healthcare Institute announced today that registration is now open for CHI's 2011 Annual Meeting. CHI's Annual Meeting focuses on the relationship between biomedical innovation and public policy. This year's theme is Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David C Brandon, MD Po Box 695, Easton, MD 21601 Ph: (301) 317-0020 | David C Brandon, MD 8464 Aveley Farm Road, Easton, MD 21601 Ph: (301) 317-0020 |
News Archive
For the first time, engineers have demonstrated an electronic device to closely monitor beating heart cells without affecting their behavior. A collaboration between the University of Tokyo, Tokyo Women's Medical University and RIKEN in Japan produced a functional sample of heart cells with a soft nanomesh sensor in direct contact with the tissue.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
CHI-California Healthcare Institute announced today that registration is now open for CHI's 2011 Annual Meeting. CHI's Annual Meeting focuses on the relationship between biomedical innovation and public policy. This year's theme is Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model.
› Verified 6 days ago
Dr. Mark P Downey, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 | |
Stephen B Lemke, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-819-0712 | |
Dr. Kathryn J. Meyer, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-819-0712 | |
Kevin John Nebab, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-819-0712 | |
Dr. John Snell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 | |
Dr. Ona M Kareiva, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 Fax: 410-819-0712 | |
Dr. Robert Middleton, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 219 S Washington St, Easton, MD 21601 Phone: 410-822-1000 |